The World Health Organization (WHO) Strongly Recommends 2 New Drugs to Treat Severe COVID-19. One of the drug types is commonly used to treat rheumatoid arthritis.
Key Facts:
• WHO issued a strong recommendation for the use of baricitinib as an alternative to interleukin-6 (IL-6) receptor blockers, or monoclonal antibodies, in combination with corticosteroids, in patients with severe or critical COVID-19
• The agency issued a conditional recommendation against the use of monoclonal antibodies ruxolitinib and tofacitinib for patients with severe or critical COVID-19.
• A conditional recommendation was also issued for the use of sotrovimab, a type of monoclonal antibody, in patients with non-severe COVID-19 but who pose a high risk of hospitalization.
The findings are a result of seven trials that included more than 4,000 patients with mild, severe, and critical COVID-19 infection. Severe cases are considered patients with confirmed COVID-19 infection who are also experiencing an oxygen level of less than 90% when breathing without assistance, as well as exhibiting signs of pneumonia and severe respiratory distress. Critical patients require life-sustaining treatment for conditions like acute respiratory distress syndrome, sepsis, and septic shock.
Source: This Snopes Article